It is known that noncanonical signaling can inhibit canonical signaling through a variety of mechanisms.13 We suggest that because of the low proportion of FZD5 positivity in the adenocarcinoma group, the noncanonical signaling could not function properly and that this subsequently led to development of hyperplasia and cancer. This evidence concerns the gene FZD5 and adenocarcinoma.